Harnessing blue light photobiomodulation for cancer therapy: Evidence from a systematic review
Conventional treatments for various types of cancer are often associated with tumor recurrence and aggressiveness. Photobiomodulation with blue light (BL; 450–470 nm) emerges as a promising alternative with antitumor effects. This systematic review, with 37 in vitro and in vivo studies from 2002 to 2024, revealed that BL reduces cell viability ...
Bárbara Evelyn Santos de Lima +6 more
wiley +1 more source
The function of MYC in base excision repair protects against RAS-induced senescence. [PDF]
Faraco CCF +17 more
europepmc +1 more source
Exposure to artificial light at night (ALAN), particularly at blue wavelengths, disrupts circadian rhythms by suppressing melatonin, thereby increasing cancer susceptibility. This systematic review consolidates evidence linking prolonged ALAN exposure to an elevated risk of breast and prostate tumors.
Gabriel Barboza +4 more
wiley +1 more source
From Chromosomal Aberrations to Transcriptome Analysis: Four Decades of Research in Bivalve Genotoxicity. [PDF]
Khatir Z, Leitão A.
europepmc +1 more source
Public Attitudes to Responding to Global Catastrophic Risks: A New Zealand Case Study
ABSTRACT Human civilization faces a range of global catastrophic risks (GCRs), including nuclear war, bioengineered pandemics, major solar storms, and uncontrolled artificial intelligence. In New Zealand, limited information exists on public views about whether the government should respond to such risks.
John Kerr, Matt Boyd, Nick Wilson
wiley +1 more source
Impact of (poly)phenol-rich dietary sources on DNA damage: insights from human intervention studies using the Comet assay - a review and perspective. [PDF]
Milev M +5 more
europepmc +1 more source
Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III. [PDF]
Sun Y +8 more
europepmc +1 more source
FEN1 is critical for rapid single-strand break repair in G1 phase. [PDF]
Burdova K +3 more
europepmc +1 more source
Assessing 5-year follow-up of core outcome set uptake for Bronchiectasis and Hidradenitis Suppurativa: a review of trial registry entries. [PDF]
Shorey C, Williamson PR, Dodd S.
europepmc +1 more source

